Nu Skin Enterprises, Inc. (NUS) Financial Statements
Industry: Drugs, Proprietaries & Druggists' Sundries (Wholesale)
In fiscal 2025, Nu Skin Enterprises reported revenue of $1.49B, down 14.3% from $1.73B the year before. Net income was $160.2M (a 10.8% net margin), or $3.18 per diluted share. Gross margin was 69.4% and operating margin was 4.4%. Operating activities generated $80.3M of cash, leaving $46.0M of free cash flow. At fiscal year end, Nu Skin Enterprises held $1.41B in total assets against $600.1M in total liabilities, including $238.6M of cash and equivalents.
Open the full interactive Nu Skin Enterprises financials → Quarterly statements, key ratios, valuation history and price charts.
Nu Skin Enterprises Key Stats
| Share Price | $5.01 |
|---|---|
| Market Cap | $243.5M |
| P/E Ratio | 1.6 |
| Revenue YoY Growth | -14.3% |
| 52-Week Range | $4.53 – $11.20 |
| Shares Outstanding | 48.6 million (basic, 2026 Q2) |
Nu Skin Enterprises Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.58B | $2.70B | $2.23B | $1.97B | $1.73B | $1.49B |
| Cost of Goods Sold | $658.0M | $675.2M | $630.9M | $611.9M | $550.2M | $453.8M |
| Gross Profit | $1.92B | $2.02B | $1.59B | $1.36B | $1.18B | $1.03B |
| Operating Income | $257.6M | $234.0M | $110.8M | $48.3M | -$151.6M | $65.8M |
| Pre-Tax Income | $256.2M | $232.5M | $89.0M | $26.6M | -$175.1M | $196.2M |
| Income Tax | $64.9M | $85.2M | -$15.8M | $18.0M | -$28.5M | $36.0M |
| Net Income | $191.4M | $147.3M | $104.8M | $8.6M | -$146.6M | $160.2M |
| Diluted EPS | $3.63 | $2.86 | $2.07 | $0.17 | -$2.95 | $3.18 |
Nu Skin Enterprises Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $364.2M | $370.3M | $320.6M | $320.1M |
| Net Income | $17.1M | $14.5M | $1.8M | -$249.8M |
| Diluted EPS | $0.34 | $0.29 | $0.04 | -$5.14 |
Nu Skin Enterprises Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $402.7M | $339.6M | $264.7M | $256.1M | $186.9M | $238.6M |
| Current Assets | $903.2M | $873.0M | $759.9M | $701.9M | $538.6M | $547.7M |
| Total Assets | $1.96B | $1.91B | $1.82B | $1.81B | $1.47B | $1.41B |
| Current Liabilities | $542.9M | $529.7M | $359.2M | $328.9M | $296.6M | $263.7M |
| Total Long-Term Debt | $335.4M | $376.3M | $402.5M | $503.0M | $393.6M | $224.2M |
| Total Liabilities | $1.06B | $993.7M | $923.7M | $984.5M | $817.5M | $600.1M |
| Shareholders' Equity | $894.3M | $912.8M | $897.3M | $822.0M | $651.5M | $805.2M |
Nu Skin Enterprises Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $379.1M | $141.6M | $108.1M | $118.6M | $111.7M | $80.3M |
| Cash From Investing | -$79.4M | -$88.7M | -$67.1M | -$134.5M | -$38.0M | $170.7M |
| Cash From Financing | -$245.2M | -$104.7M | -$99.5M | $10.7M | -$133.2M | -$202.4M |
| Free Cash Flow | $315.3M | $73.0M | $49.0M | $60.1M | $70.2M | $46.0M |
Figures from Nu Skin Enterprises' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Nu Skin Enterprises financials page for every line item.
Nu Skin Enterprises Company Profile
| Ticker | NUS |
|---|---|
| Exchange | NYSE |
| Industry | Drugs, Proprietaries & Druggists' Sundries (Wholesale) |
| Headquarters | Provo, Utah |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001021561 |
Frequently Asked Questions
What was Nu Skin Enterprises' revenue in fiscal 2025?
Nu Skin Enterprises (NUS) reported revenue of $1.49B for fiscal 2025.
What is Nu Skin Enterprises' annual revenue history?
Nu Skin Enterprises' annual revenue by fiscal year: 2020: $2.58B; 2021: $2.70B; 2022: $2.23B; 2023: $1.97B; 2024: $1.73B; 2025: $1.49B.
What was Nu Skin Enterprises' net income in fiscal 2025?
Nu Skin Enterprises reported net income of $160.2M for fiscal 2025.
What was Nu Skin Enterprises' earnings per share (EPS) in fiscal 2025?
Nu Skin Enterprises' diluted EPS was $3.18 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Nu Skin Enterprises generate in fiscal 2025?
Nu Skin Enterprises generated $46.0M of free cash flow in fiscal 2025.
What was Nu Skin Enterprises' revenue last quarter?
In its most recent reported quarter (2026 Q2), Nu Skin Enterprises reported revenue of $320.1M.
How much debt does Nu Skin Enterprises have?
Nu Skin Enterprises reported $224.2M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Nu Skin Enterprises are outstanding?
Nu Skin Enterprises reported a weighted average of 48.6 million basic shares outstanding in 2026 Q2.
What is Nu Skin Enterprises' market cap?
Based on its latest closing price, Nu Skin Enterprises (NUS) has a market capitalization of about $243.5M.
When does Nu Skin Enterprises' fiscal year end?
Nu Skin Enterprises' fiscal year end, as registered with the SEC, is December 31.
Where is Nu Skin Enterprises headquartered?
Nu Skin Enterprises lists its business address in Provo, Utah in its SEC filings.